ZMYND8 Expression in Breast Cancer Cells Blocks T-Lymphocyte Surveillance to Promote Tumor Growth
Open Access
- 4 November 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (1), 174-186
- https://doi.org/10.1158/0008-5472.can-20-1710
Abstract
These findings show that ZMYND8 is a new negative and intrinsic regulator of the innate immune response in breast tumor cells, and that ZMYND8 may be a possible target for antitumor immunotherapy.Other Versions
Funding Information
- Mary Kay Foundation (08-19)
- HHS | NIH | National Cancer Institute (R01CA222393)
- Cancer Prevention and Research Institute of Texas (RR140036)
- Cancer Prevention and Research Institute of Texas (RP190358)
- Susan G. Komen (CCR16376227)
- Welch Foundation (I-1903-20190330)
- HHS | NIH | National Institute of General Medical Sciences (R35GM124693)
- HHS | NIH | National Institute on Aging (R01AG066166)
- Cancer Prevention and Research Institute of Texas (RP170671)
- Welch Foundation (I-1939-20160319)
This publication has 50 references indexed in Scilit:
- Nivolumab plus Ipilimumab in Advanced MelanomaThe New England Journal of Medicine, 2013
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon PathwayScience, 2013
- Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progressionProceedings of the National Academy of Sciences of the United States of America, 2012
- Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancerBreast Cancer Research, 2011
- STAT3 Negatively Regulates Type I IFN-Mediated Antiviral ResponseThe Journal of Immunology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- Global changes in STAT target selection and transcription regulation upon interferon treatmentsJournal of Bone and Joint Surgery, 2005
- Mature dendritic cells differentiated in the presence of interferon-b and interleukin-3 prime functional antigen-specific CD8+ T cellsClinical and Experimental Immunology, 2005
- The Involvement of TNF-α-Related Apoptosis-Inducing Ligand in the Enhanced Cytotoxicity of IFN-β-Stimulated Human Dendritic Cells to Tumor CellsThe Journal of Immunology, 2001